Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Aggrenox (Aspirin/Extended-Release Dipyridamole) Capsules
Company:  Boehringer Ingelheim Pharmaceuticals, Inc.
Application No.:  20884
Approval Date: 11/22/1999


Date created: July 02, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.